SCHEMBL13627823

SCHEMBL13627823

CC(=O)OCS(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817089 0.80 ALDH1A1 (0.48)
SCHEMBL4444589 0.78
Ammonia Solution, Strong SCHEMBL28082774 0.76 ALDH1A1 (0.43)
SCHEMBL28082703 0.76 ALDH1A1 (0.43)
SCHEMBL27767615 0.76
SCHEMBL28083147 0.76 ALDH1A1 (0.43)
SCHEMBL28082655 0.76 ALDH1A1 (0.43)
SCHEMBL28082894 0.76 ALDH1A1 (0.43)
SCHEMBL28082329 0.76 ALDH1A1 (0.43)
Ethyl Acetate SCHEMBL16906695 0.76 ALDH1A1 (0.74)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102159557-A Piperazine d3 and 5-ht2a receptor modulators HOFFMANN LA ROCHE 2011-08-17 CN disclosed
CN-101945874-A 3-substituted-4-oxo-3, 4-dihydro-imidazo [5,1-d ] [1,2,3,5] -tetrazine-8-carboxamides as anticancer agents PHARMINOX LTD 2011-01-12 CN disclosed
US-7619092-B2 Piperidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-11-17 US disclosed
US-7619092-B2 Piperidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-11-17 US disclosed
US-7585919-B2 Polymer derived from monomers with long-chain aliphatic, poly(oxyalkylene) and substrate-reactive groups 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-09-08 US disclosed
US-20080075960-A1 CURABLE COMPOSITIONS AND BIOFILM-RESISTANT COATINGS THEREFROM 3M INNOVATIVE PROPERTIES COMPANY 2008-03-27 US disclosed